Indaptus Therapeutics
Stock Forecast, Prediction & Price Target
Indaptus Therapeutics Financial Estimates
Indaptus Therapeutics Revenue Estimates
Indaptus Therapeutics EBITDA Estimates
Indaptus Therapeutics Earnings per Share Estimates
Passed | Analyst forecast | ||||||
---|---|---|---|---|---|---|---|
Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $47.37M Low: $47.37M High: $47.37M avg. 0% |
Net Income
% change YoY
| $-7.69M N/A | $-13.73M -78.51% | $-15.42M -12.29% | Avg: $-23.68M Low: $-12.09M High: $-11.34M avg. -53.56% | Avg: $-22.80M Low: $-10.33M High: $-10.33M avg. 3.70% | Avg: $-9.82M Low: $-9.82M High: $-9.82M avg. 56.90% | Avg: $3.52M Low: $3.52M High: $3.52M avg. 135.89% |
EBITDA
% change YoY
| $-7.72M N/A | $-14.90M -92.93% | $-16.37M -9.84% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
EPS
% change YoY
| -$1.88 N/A | -$1.66 11.70% | -$1.84 -10.84% | Avg: -$1.4 Low: -$1.44 High: -$1.35 avg. 24.18% | Avg: -$1.23 Low: -$1.23 High: -$1.23 avg. 11.82% | Avg: -$1.17 Low: -$1.17 High: -$1.17 avg. 4.87% | Avg: $0.42 Low: $0.42 High: $0.42 avg. 135.89% |
Operating Expenses
% change YoY
| $7.72M N/A | $14.91M 92.91% | $16.37M 9.84% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
FAQ
What is Indaptus Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 35.73% in 2025-2028.
We have gathered data from 1 analysts. Their low estimate is -12.09M, average is -23.68M and high is -11.34M.
What is Indaptus Therapeutics stock revenue growth forecast?
We have gathered data from 1 analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.
What is Indaptus Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 44.19% in 2025-2028.
We have gathered data from 1 analysts. Their low earnings per share estimate is -$1.44, average is -$1.4 and high is $-1.35.